Glenmark and Ichnos launch Ichnos Glenmark Innovation to accelerate new drug discovery in cancer… EP News Bureau Jan 30, 2024 The newly formed IGI features a pipeline of three innovative oncology molecules targeting multiple myeloma, acute myeloid leukemia…
Ichnos Sciences signs licensing pact with Astria Therapeutics for OX40 antagonist monoclonal… EP News Bureau Oct 12, 2023 Astria Therapeutics is granted global rights to develop and commercialise OX40 portfolio, comprised of Telazorlimab and its…
